Chuangxin Medical's 7-Day 4-Board Surge: Boling Brain-Computer's Brain-Computer Interface Products Yet to Officially Launch, Limited Sales via Scientific Research Institution Collaborations
2025-08-13 / Read about 0 minute
Author:小编   

Chuangxin Medical has announced that its stock has recently undergone abnormal fluctuations, marked by a closing price increase deviation exceeding 20% for three consecutive trading days. Boling Brain-Computer (Hangzhou) Technology Co., Ltd., in which Chuangxin holds a 40% equity stake, specializes in the research and development of brain-computer interface technology and product production. Currently, Boling Brain-Computer's products have not been officially launched and are only available in limited quantities through collaborations with scientific research institutions. Notably, Boling Brain-Computer incurred losses of 6.6017 million yuan in 2023 and 8.6641 million yuan in 2024.